• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Q-Pharm appoints Tufail Syed as CEO

Q-Pharm appoints Tufail Syed as CEO

May 10, 2017
CenterWatch Staff

Q-Pharm, an Australian early phase CRO, has announced that Dr. Tufail Syed has been appointed as the new CEO of the company.

The Q-Pharm board has thanked interim CEO Michael Creevey for his excellent support and leadership during the transition period prior to Dr. Syed’s appointment.

Dr. Syed has 17 years of clinical research experience gained in academia, large pharmaceutical companies and global CROs.

Most recently, he held the role of regional head of Global Testing Services for the Asia-Pacific at Covance. Prior to that, Dr. Syed held executive and senior leadership roles at Medpace and Eli Lilly.

He trained as a physician in India before relocating to the U.S., where he did further training and worked as a medical researcher. He received an MBA from Rutgers Business School in New Jersey.

“Q-Pharm has proved itself to be a reliable partner to the clinical research enterprise over the last 15 years, through its high quality, safety and operational excellence,” Dr. Syed said. “I am delighted to join a best-in-class clinical research team that is dedicated to providing exceptional services to our clients and improving lives through clinical research.”

Under his leadership, Q-Pharm will maintain its focus on reliability and quality, while expanding activities to new markets and offerings.

Founded in 2002, Q-Pharm has built an enviable reputation in the recruitment and conduct of early-phase clinical trials. Q-Pharm’s foundations in bioequivalence, vaccine and disease challenge models in a broad range of healthy volunteer and patient-based trials have grown into widely acknowledged expertise. Q-Pharm has conducted more than 400 clinical trials in its state-of-the-art facilities located at Brisbane’s QIMR Berghofer Medical Research Institute. Q-Pharm provides comprehensive, high-quality services for its clients, and conducts clinical trials in accordance with all applicable national and international safety standards and guidelines. While safety and quality remain the heart of the business, Q-Pharm proactively seeks innovative and intelligent growth opportunities in the area of clinical trials.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing